Preliminary Evidence of the Potent and Selective Adenosine A2B Receptor Antagonist PSB-603 in Reducing Obesity and Some of Its Associated Metabolic Disorders in Mice

The adenosine A(2A) and A(2B) receptors are promising therapeutic targets in the treatment of obesity and diabetes since the agonists and antagonists of these receptors have the potential to positively affect metabolic disorders. The present study investigated the link between body weight reduction,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotańska, Magdalena, Dziubina, Anna, Szafarz, Małgorzata, Mika, Kamil, Bednarski, Marek, Nicosia, Noemi, Temirak, Ahmed, Müller, Christa E., Kieć-Kononowicz, Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656786/
https://www.ncbi.nlm.nih.gov/pubmed/36362227
http://dx.doi.org/10.3390/ijms232113439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656786/
https://www.ncbi.nlm.nih.gov/pubmed/36362227
http://dx.doi.org/10.3390/ijms232113439

Ejemplares similares